Monosaccaridi

L-Ribose is a monosaccharide that is a constituent of ribonucleic acid, deoxyribonucleic acid and other compounds. It can be found in small quantities in most living organisms. L-Ribose has been modified to include fluorine atoms at the C2 position. The addition of fluorine atoms increases the stability of the molecule and its resistance to hydrolysis by esterases. L-Ribose has also been modified with methyl groups at the C3 position and glycosylation at the C4 position. This modification preserves the biological activity of L-Ribose and increases its water solubility. L-Ribose is used as a building block for custom synthesis, such as peptides or oligosaccharides.>>END>>

The synthesis of benzyl 2,3-O-isopropylidene-6-O-trityl-5-keto-a-D-mannofuranoside 5-oxime is accomplished by the reaction of a D-mannose with phloroglucinol in the presence of sodium methoxide. The product is purified by column chromatography.

(2R,4R)-2-[L-Xylo-tetrahydroxybut-1-yl]-1,3-thiazolidine-4-carboxylic acid is a methylated saccharide that can be used for the synthesis of glycosides and other carbohydrate derivatives. (2R,4R)-2-[L-Xylo-tetrahydroxybut-1-yl]-1,3-thiazolidine-4-carboxylic acid has been shown to react with various reagents such as iodine and bromine. This product has been synthesized by Click modification.

2-Azidoethyl 2-O-benzoyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-a-D-mannopyranoside is a synthetic sugar that has been modified with fluorination and glycosylation. The carbohydrate is made of a complex chain of monosaccharides and saccharides. It is the CAS number for this chemical agent.

4'-Hydroxytrazodone b-D-glucuronide is a modification of the drug 4'-hydroxytrazodone, which is used to treat hypertension and depression. The modification prevents the degradation of 4'-hydroxytrazodone by glucuronyl transferase enzymes in the liver, prolonging its half-life. It is synthesized from the glycogen or starch of plants such as corn, wheat, or potatoes. This compound can also be found in natural sources such as honey and fruit juices.

Dehydroclindamycin is a semisynthetic antibiotic that belongs to the class of antibiotics known as lincosamides. It is used in clinical treatment for bacterial infections. Dehydroclindamycin acts by interfering with the bacterial ribosome and prevents the formation of proteins required for cell division. This drug may be susceptible to degradation by hydrolysis or oxidation, which can lead to impurities. Dehydroclindamycin is produced by hydrogenation of clindamycin hydrochloride using a Raney nickel catalyst, followed by chromatography. The spectrum of dehydroclindamycin consists of antibacterial activity against gram-positive bacteria such as Staphylococcus aureus and Enterococcus faecalis and gram-negative bacteria such as Escherichia coli and Klebsiella pneumoniae.

2,6-Anhydro-3-deoxy-D-lyxo-hept-2-enonimidamide monohydrochloride is a fluorinated sugar that has been custom synthesized to be used as a glycosylation or polysaccharide modification. It has been methylated and click modified to increase its purity. 2,6-Anhydro-3-deoxy-D-lyxo-hept-2-enonimidamide monohydrochloride is also known by the CAS number 180336-29-2.

L-Glycero-D-manno heptose peracetate is a custom make to order saccharide.

D-Arabinose-5-13C is a fluorinated monosaccharide that has been used in the synthesis of oligosaccharides and polysaccharides. It can be custom synthesized to meet customer specifications. D-Arabinose-5-13C is a white, crystalline powder that is soluble in water. This compound can be methylated or glycosylated for further modification.

2-Hydroxyimipramine b-D-glucuronide is a custom synthesis, modification, and fluorination of the drug 2-hydroxyimipramine. The methyl group from the molecule is replaced with a fluoro group. This modification leads to a new compound with improved pharmacokinetic properties. The new compound also has glycosylation sites on the sugar ring that are not present in the parent drug. This modification may lead to an increase in the therapeutic efficacy of 2-hydroxyimipramine b-D-glucuronide as it interacts with other drugs and increases their bioavailability.

D-2'-Deoxyribofuranosyl-3-guanylurea is a custom synthesis that is used as an intermediate in the glycosylation of oligosaccharides and polysaccharides. D-2'-Deoxyribofuranosyl-3-guanylurea is a modified sugar that has been fluorinated, methylated, and glycosylated. This compound is used to synthesize complex carbohydrates that are important for various biological processes.

Phenyl 3,4,6-tri-O-acetyl-2-deoxy-1-thio-2-(2,2,2-trichloroethoxyformamido)-b-D-galactopyranoside is a high purity and custom synthesis sugar that has been modified with fluorination and glycosylation. This product is also methylated and modified with an oligosaccharide. Phenyl 3,4,6-tri-O-acetyl-2-deoxy-1-thio - 2-(2,2,2 trichloroethoxyformamido)-b - D - galactopyranoside is used as a saccharide in the synthesis of complex carbohydrates.

1,4:3,6-Dianhydrogalactitol (1,4:3,6-DAG) is a glycosylated sugar that belongs to the group of complex carbohydrates. It has been shown to be an effective inhibitor of methylation and Click modification reactions. 1,4:3,6-DAG also inhibits the polymerization of saccharides and oligosaccharides. This product is custom synthesized for research purposes and can be provided in high purity.

3-Deoxy-3-fluoro-D-myo-inositol 1,4,5-trisphosphate hexasodium salt is a synthetic sugar that has been modified with fluorination and glycosylation. It is used for the synthesis of oligosaccharides and monosaccharides. 3-Deoxy-3-fluoro-D-myo-inositol 1,4,5-trisphosphate hexasodium salt is a carbohydrate that can be found in complex carbohydrates such as glycolipids and glycoproteins. The CAS number for this compound is 129365–68–0.

(1R,2R,3S,4S,5S)-1-(tert-Butyldiphenyl)silyloxymethyl-2,3-dioxy-O,O-isopropylidenebicyclo[3.1.0]hexan-4-ol is a sugar derivative that is used in the synthesis of saccharides and oligosaccharides. It can be fluorinated using the Click modification to create synthetic sugars for use in glycosylation reactions. This compound can be custom synthesized to meet your needs and specifications.

a-D-Glucosyl hesperidin is a water-soluble drug that has been shown to have antioxidant properties. It inhibits the activity of certain enzymes, such as phospholipase A2 and lipoxygenase, which are involved in inflammation. The compound has also been shown to inhibit cancer cells in vitro by inducing apoptosis and inhibiting cell proliferation. Glibenclamide, the active form of a-D-glucosyl hesperidin, is an orally active hypoglycemic agent used to treat diabetes mellitus type 2 and gestational diabetes. It works by stimulating insulin release from beta cells in the pancreas and promoting insulin sensitivity in peripheral tissues. This compound also inhibits annexin V binding to phosphatidylserine, which leads to apoptosis.